Moleculin Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Moleculin Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Moleculin Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $450K, a 17.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $450K -$97K -17.7% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $475K +$117K +32.7% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $500K +$119K +31.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $524K +$121K +30% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $547K +$122K +28.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $358K -$88K -19.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $381K +$300K +370% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $403K +$296K +277% Dec 31, 2022 10-K 2024-03-22
Q3 2022 $425K +$294K +224% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $446K +$291K +188% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $81K -$98K -54.7% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $107K -$95K -47% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $131K -$93K -41.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $155K -$90K -36.7% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $179K -$87K -32.7% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $202K -$85K -29.6% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $224K -$82K -26.8% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $245K +$142K +138% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $266K +$160K +151% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $287K Dec 31, 2019 10-K 2021-03-24
Q3 2019 $306K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $103K Jun 30, 2019 10-Q 2019-08-16
Q1 2019 $106K Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.